Dialog Semiconductor Plc. 08.12.2015 18:30 Dissemination of a Voting Rights Announcement, transmitted by DGAP - a service of EQS Group AG. The issuer is solely responsible for the content of this announcement. --------------------------------------------------------------------------- On 4 December 2015 a form TR-1 has been received by the Company from Deutsche Bank AG London, United Kingdom. TR-1: NOTIFICATION OF MAJOR INTEREST IN SHARES 1. Identity of the issuer or the underlying issuer of existing shares to which voting rights are attached: Dialog Semiconductor Plc 2. Reason for the notification: An acquisition or disposal of voting rights An acquisition or disposal of qualifying financial instruments which may result in the acquisition of shares already issued to which voting rights are attached An acquisition or disposal of instruments with similar economic effect to qualifying financial instruments 3. Full name of person(s) subject to the notification obligation: Deutsche Bank AG 4. Full name of shareholder(s) (if different from 3.): N/A 5. Date of the transaction and date on which the threshold is crossed or reached if different: 2 December 2015 6. Date on which the issuer notified: 4 December 2015 7. Threshold(s) that is/are crossed or reached: Above 5% 8. Notified details: A: Voting rights attached to shares Class / type of shares: GB0059822006 Situation previous to the triggering transaction Number of shares: Below notifiable threshold Number of voting rights: Below notifiable threshold Resulting situation after the triggering transaction Number of shares: 3,411,604 Number of voting rights direct: 3,411,604 Number of voting rights indirect: N/A % of voting rights direct: 4.38% % of voting rights indirect: N/A B: Qualifying Financial Instruments: Resulting situation after the triggering transaction Warrants Call Option Expiration date: 14 December 2016 26 February 2016 Exercise/conversion period: Number of voting rights that may be acquired if the instrument is exercised/converted: 86,212 125,000 %age of voting rights: 0.11% 0.16% C: Financial Instruments with similar economic effect to Qualifying Financial Instruments Resulting situation after the triggering transaction Type of financial instrument: Swaps Exercise price: 40.00 Expiration date: 12 March 2019 Number of voting rights instrument refers to: 335,862 Percentage of voting rights: Nominal: 0.43% Delta: 0.43% Total (A+B+C) Number of voting rights: 3,958,678 Percentage of voting rights: 5.08% 9. Chain of controlled undertakings through which the voting rights and/or the financial instruments are effectively held, if applicable: Deutsche Bank AG: 5.08% 10. to 12. Proxy Voting: N/A 08.12.2015 The DGAP Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases. Media archive at www.dgap-medientreff.de and www.dgap.de --------------------------------------------------------------------------- Language: English Company: Dialog Semiconductor Plc. Tower Bridge House, St. Katharine's Way E1W 1AA London United Kingdom Internet: www.dialog-semiconductor.com End of Announcement DGAP News-Service ---------------------------------------------------------------------------
DGAP-PVR: Dialog Semiconductor Plc.: Release according to
Top 10 Most Recent News Articles
Championing Change: USTA Mid-Atlantic Gala's Impact
A Night to Remember: USTA Mid-Atlantic's Gala Who would've thought tennis could wield such transformative power? This ain't your average sport gala. Last Saturday, a crowd of over 300 gathered at the Ritz-Carlton Tysons Corner for the USTA Mid-Atlantic Foundation's 2026 Tennis Creates Gala. Hosted by the formidable Malika Andrews, this event wasn't just a fancy...
Continue Reading
YSTUDIO's Pens: A Nod to the Power of Writing
Slow Down, Write On: A New Era for Stationery In a world where sentiments zip around with a swipe, here we find YSTUDIO tapping into something analog and profound. Their latest offerings—a 'Brand Day Gift Box' and the 'Inner Universe' pen series—are more than just high-end stationery. They’re an invitation to reconnect with the written word, a gesture to slow our...
Continue Reading
Shenzhen's Vision Unveiled: APEC 2026 Promo Debut
Shenzhen's Spotlight Moment at APEC 2026 When Shenzhen announced its promotional video for the 2026 APEC Economic Leaders' Meeting, it wasn't just about standard tourism glitz. This was a show of force, a bold step onto the main stage of global politics and economics. The video's launch wasn’t merely an audio-visual delight—it staked a claim in shaping the future...
Continue Reading
JOYEE N01 Debuts Globally with First 2,000 Deliveries
JOYYE N01 Breaks into the Global Market Now, here we go, folks—a Chinese car with ambitions bigger than the Sahara. On October 28, the JOYEE N01 rolled off the assembly line and into the international scene with a lot of fanfare at FAW's Yancheng Branch. Mark my words, this isn't just another model trying to strut into the global auto arena. This event delivered the...
Continue Reading
EZaccessMD Data Breach: Class Action Lawsuit Looms
Data breaches are the bogeyman no one wants lurking in the shadows, and when it’s your personal info at stake, folks rightfully squirm. This recent fiasco at EZaccessMD is one of those unsettling incidents. The word on the street isn't pretty: sensitive medical data has slipped through the cracks, leaving Edelson Lechtzin LLP, a heavyweight in class action maneuvers, to...
Continue Reading
Novo's CagriSema Trials Show Promising Weight Loss
Decoding CagriSema's Promise Let me tell you, when those corporate folks from Novo Nordisk announce something big like their investigational drug CagriSema at ObesityWeek® 2026, it’s time to take notice. This isn’t just your average press release about some new weight loss fad. We’re talking about a phase 3 REDEFINE 1 trial that opens up a treasure chest of data...
Continue Reading
Novo's CagriSema Trial Shows Promising Obesity Results
Novo's Latest Weight Loss Gamble Well, look what we have here. Novo Nordisk is shaking up the obesity treatment scene with some bold numbers from their REDEFINE 9 trial. The investigational CagriSema combo of amylin analog and GLP-1 receptor agonist has churned out an eyeball-popping near 21% weight loss. For context, we're staring down the barrel of numbers far meatier...
Continue Reading
Ambrosia Biosciences Unveils Promising Nonclinical Metabolic Data
Ambrosia's Latest Nonclinical Revelations Ambrosia Biosciences has just thrown out some major bait at ObesityWeek® 2026. The highlight? New nonclinical data profiles for two of their understudy small molecule programs—AMB-895 and AMB-131. It may sound niche, but in this sector, promising data spins heads. Their GLP-1 receptor agonist, AMB-895, and GIP receptor...
Continue Reading
HONGQI's EHS4 Launch in Europe: Bridging East and West
Revving Up a New Chapter: HONGQI in Venice There's a new player in the European automotive scene, and it's rolling in with more style than a Venetian gondola. HONGQI, a name that's been turning gears in China since '58, is packing its suitcases full of Eastern elegance and landing straight in Venice with the all-electric EHS4. On November 16, the brand is set to unveil...
Continue Reading
CVS Study: GLP-1 Drugs Effective But Costly
Can GLP-1s Deliver Value at Their Current Price? Alright, folks, here's a real-world gut check from CVS Health. They crunched some numbers using Aetna's anonymized claims data, and the results are eye-opening. These GLP-1s are showing promising health outcomes—lower hospital visits, better clinical results, yada yada. But when it comes to savings, they ain't quite...
Continue ReadingTop 5 Most Recently Viewed Articles
WISeKey Enhances Digital ID Solutions Across Africa
WISeKey Expands Its Digital Identity Footprint Across Africa WISeKey International Holding Ltd is making significant strides in transforming digital identity solutions not only within Seychelles but also expanding into several other African nations. As a prominent player in cybersecurity, blockchain, and IoT, WISeKey is set to revolutionize how national ID systems...
Continue Reading
How to Send Event Leads Directly into Your CRM
Trade shows and conferences generate some of the highest-intent leads a sales team will ever encounter. Yet many of those conversations never convert—not because the prospect lost interest, but because the follow-up arrived too late or the contact details were lost somewhere between a badge scanner and a spreadsheet. Research from event marketing surveys consistently...
Continue Reading
Dreame Technology's Innovative Smart Home Solutions at CES 2025
Dreame Technology Showcases Innovative Solutions at CES 2025 Dreame Technology, a pioneer in smart home solutions, has made waves at CES 2025 with the introduction of its next-generation smart home ecosystem. This new system streamlines home management and enhances everyday living through intelligent appliances that are easy to use and highly efficient. Revolutionizing...
Continue Reading
Astemo Flexes Aftermarket Muscles at 2026 AAPEX & SEMA
Ah, nothing gets car enthusiasts more revved up than a good old-fashioned auto show unveiling. Astemo Americas is strutting its stuff at the 2026 AAPEX and SEMA shows, and they're not just shooting the breeze—this company has got some serious aftermarket muscle to flex. Pumping Up the Aftermarket Game Astemo's not sitting on its hands when it comes to expanding its...
Continue Reading
Cocoa Prices Plummet, Boosting Chocolate Makers Before Holidays
Cocoa Prices Reach New Lows Recently, cocoa futures dropped to their lowest point in nearly two years, which is quite timely as we approach the season for hot chocolate and festive gifting. This price decline acts as a unique advantage for chocolate manufacturers who are just starting to see some relief after facing escalating ingredient costs over the past year, coupled...
Continue Reading